Literature DB >> 25472951

Smoldering multiple myeloma: special considerations surrounding treatment on versus off clinical trials.

Elisabet E Manasanch1, Neha Korde2, Sham Mailankody3, Nishant Tageja3, Manisha Bhutani3, Mark Roschewski3, Ola Landgren4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25472951      PMCID： PMC4258744          DOI： 10.3324/haematol.2014.107516

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  16 in total

1.  Regarding empiricism and rationalism in medicine and 2 medical worldviews.

Authors:  Vinay Prasad
Journal:  Mayo Clin Proc       Date:  2014-01       Impact factor: 7.616

2.  Clinical trial evidence supporting FDA approval of novel therapeutic agents, 2005-2012.

Authors:  Nicholas S Downing; Jenerius A Aminawung; Nilay D Shah; Harlan M Krumholz; Joseph S Ross
Journal:  JAMA       Date:  2014 Jan 22-29       Impact factor: 56.272

Review 3.  Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma: biological insights and early treatment strategies.

Authors:  Ola Landgren
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2013

4.  Whole-genome sequencing of multiple myeloma from diagnosis to plasma cell leukemia reveals genomic initiating events, evolution, and clonal tides.

Authors:  Jan B Egan; Chang-Xin Shi; Waibhav Tembe; Alexis Christoforides; Ahmet Kurdoglu; Shripad Sinari; Sumit Middha; Yan Asmann; Jessica Schmidt; Esteban Braggio; Jonathan J Keats; Rafael Fonseca; P Leif Bergsagel; David W Craig; John D Carpten; A Keith Stewart
Journal:  Blood       Date:  2012-04-23       Impact factor: 22.113

5.  Modeling progression risk for smoldering multiple myeloma: results from a prospective clinical study.

Authors:  Benjamin M Cherry; Neha Korde; Mary Kwok; Elisabet E Manasanch; Manisha Bhutani; Marcia Mulquin; Diamond Zuchlinski; Mary Ann Yancey; Irina Maric; Katherine R Calvo; Raul Braylan; Maryalice Stetler-Stevenson; Constance Yuan; Prashant Tembhare; Adriana Zingone; Rene Costello; Mark J Roschewski; Ola Landgren
Journal:  Leuk Lymphoma       Date:  2013-07-29

6.  Clinical, genomic, and imaging predictors of myeloma progression from asymptomatic monoclonal gammopathies (SWOG S0120).

Authors:  Madhav V Dhodapkar; Rachael Sexton; Sarah Waheed; Saad Usmani; Xenofon Papanikolaou; Bijay Nair; Nathan Petty; John D Shaughnessy; Antje Hoering; John Crowley; Robert Z Orlowski; Bart Barlogie
Journal:  Blood       Date:  2013-10-21       Impact factor: 22.113

Review 7.  Smoldering multiple myeloma requiring treatment: time for a new definition?

Authors:  Angela Dispenzieri; A Keith Stewart; Asher Chanan-Khan; S Vincent Rajkumar; Robert A Kyle; Rafael Fonseca; Prashant Kapoor; P Leif Bergsagel; Arleigh McCurdy; Morie A Gertz; Martha Q Lacy; John A Lust; Stephen J Russell; Steven R Zeldenrust; Craig Reeder; Vivek Roy; Francis Buadi; David Dingli; Suzanne R Hayman; Nelson Leung; Yi Lin; Joseph Mikhael; Shaji K Kumar
Journal:  Blood       Date:  2013-10-21       Impact factor: 22.113

8.  Importance of achieving stringent complete response after autologous stem-cell transplantation in multiple myeloma.

Authors:  Prashant Kapoor; Shaji K Kumar; Angela Dispenzieri; Martha Q Lacy; Francis Buadi; David Dingli; Stephen J Russell; Suzanne R Hayman; Thomas E Witzig; John A Lust; Nelson Leung; Yi Lin; Steven R Zeldenrust; Arleigh McCurdy; Philip R Greipp; Robert A Kyle; S Vincent Rajkumar; Morie A Gertz
Journal:  J Clin Oncol       Date:  2013-11-18       Impact factor: 44.544

9.  Pursuing the curative blueprint for early myeloma.

Authors:  Mark Roschewski; Neha Korde; S Peter Wu; Ola Landgren
Journal:  Blood       Date:  2013-06-19       Impact factor: 22.113

10.  Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy.

Authors:  Jens G Lohr; Petar Stojanov; Scott L Carter; Peter Cruz-Gordillo; Michael S Lawrence; Daniel Auclair; Carrie Sougnez; Birgit Knoechel; Joshua Gould; Gordon Saksena; Kristian Cibulskis; Aaron McKenna; Michael A Chapman; Ravid Straussman; Joan Levy; Louise M Perkins; Jonathan J Keats; Steven E Schumacher; Mara Rosenberg; Gad Getz; Todd R Golub
Journal:  Cancer Cell       Date:  2014-01-13       Impact factor: 31.743
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.